Lauren Sharon
Nurse Practitioner · Winter Park, FLNPI 1932213766
Payments from drug & device makers
Across 67 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$372
- AbbVie$111
- Pharmacyclics LLC, An Abbvie Company$87
- Johnson & Johnson$80
- Novartis$65
- E.r. Squibb & Sons, L.L.C.$63
- plus $527 from 19 others
What the payments were for
- Food & beverage$1,307100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 20 | $372 |
| AbbVie | 4 | $111 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $87 |
| Johnson & Johnson | 4 | $80 |
| Novartis | 3 | $65 |
| E.r. Squibb & Sons, L.L.C. | 3 | $63 |
| Pfizer | 3 | $62 |
| Myovant Sciences Inc. | 3 | $47 |
| Beigene USA, Inc. | 3 | $42 |
| AstraZeneca | 1 | $35 |
| CSL Behring | 2 | $35 |
| Jazz Pharmaceuticals Inc. | 2 | $33 |
| Genentech USA, Inc. | 2 | $31 |
| ADC Therapeutics America, Inc. | 2 | $30 |
| Sanofi | 1 | $26 |
| Taiho Oncology, Inc. | 1 | $25 |
| Karyopharm Therapeutics Inc. | 1 | $24 |
| Tersera Therapeutics LLC | 1 | $22 |
| Gilead | 1 | $19 |
| EMD Serono, Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| Beone Medicines USA, Inc. | 1 | $17 |
| GSK | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Adaptive Biotechnologies Corporation | 1 | $12 |
How this compares
$1,307 in reported general payments places this provider in the 75th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 46 | $46,592 |
| Levothyroxine Sodium | 63 | $713 |
| Tamoxifen Citrate | 26 | $508 |
| Letrozole | 20 | $477 |
| Dexamethasone | 24 | $400 |
| Prednisone | 77 | $396 |
| Hydroxyurea | 36 | $375 |
| Ondansetron OdtOndansetron | 16 | $198 |
| Gabapentin | 26 | $185 |
| Potassium Chloride | 18 | $156 |
| Alendronate Sodium | 13 | $131 |
| Pantoprazole Sodium | 20 | $127 |
| Methylprednisolone | 18 | $112 |
| Tamsulosin Hcl | 12 | $112 |
| Sertraline Hcl | 23 | $93 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $62 | $46,59246 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Winter Park
- Adissa PerezWinter Park$370K
- Deborah GliddenWinter Park$69K
- Ernestina Kyei DonkorWinter Park$22K
- Jolanta BaginskiClearwater$494K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.